Segev is studying the effectiveness of a third dose, hoping that “there is something that can ultimately be done for transplant patients.” He wants to start a formal intervention trial soon and provide a third shot in the clinical setting to ensure safety and track ...
from Google Alert - health https://ift.tt/3dejTQr
via IFTTT
0 comments:
Post a Comment